BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:49 PM
 | 
Mar 07, 2008
 |  BC Extra  |  Company News

FDA approves updated ESA labels

Amgen (NASDAQ:AMGN) said FDA approved updated safety information for erythropoiesis-stimulating agents (ESAs), including an updated boxed warning. The updated boxed warning states that ESAs shortened overall survival and/or time-to-tumor progression in clinical studies in patients with breast, non-small cell lung,...

Read the full 184 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >